NCT05939479View on ClinicalTrials.gov

Antistaphylococcal Betalactam and Emergence of Resistance

CompletedOBSERVATIONAL
Enrollment

644

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

May 1, 2023

Study Completion Date

June 1, 2023

Conditions
Bacterial ResistanceMethicillin-Sensitive Staphylococcus Aureus Infection
Trial Locations (1)

54500

Lefevre, Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT05939479 - Antistaphylococcal Betalactam and Emergence of Resistance | Biotech Hunter | Biotech Hunter